An Act providing for insurance coverage for vaginal estrogen for the treatment of menopausal symptoms and urinary tract infections.
(Remarks see House Journal Page )
Summary
The bill obligates health insurance policies issued or renewed in Pennsylvania after the law takes effect to include coverage for vaginal estrogen used to treat menopausal symptoms and prevent urinary tract infections. Coverage must encompass all FDA‑approved vaginal estrogen drugs and devices, though insurers may still apply standard medical‑necessity, cost‑sharing and utilization‑review rules. The goal is to improve access to a common therapy for women experiencing menopause.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when HB 2545 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 2545 freeOr ask your AI assistant about HB 2545 directly:
Add to Claude, ChatGPT or Cursor